The diagnosis and attribution of asbestos-related diseases in an Australian context: Report of the Adelaide Workshop on Asbestos-related Diseases. October 6-7, 2000

International Journal of Occupational and Environmental Health

Volumn 10, Issue 1, 2004, Pages 40-46

  Henderson, Douglas W ^b   Jones, Michael L ^b   De Klerk, Nicholas ^b   Leigh, James ^b   Musk, A William ^b   Shilkin, Keith B ^a   Williams, Vincent M ^b  

^a PathCentre   (Australia)

^b NONE

Author keywords

Asbestos; Asbestos related diseases; Attribution; Compensation; Lung cancer; Mesothelioma

Indexed keywords

ASBESTOS; MINERAL FIBER;

ASBESTOSIS; ATELECTASIS; AUSTRALIA; CANCER DIAGNOSIS; CANCER SCREENING; CONFERENCE PAPER; COST BENEFIT ANALYSIS; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG CANCER; LUNG FIBROSIS; MALIGNANT MESOTHELIOMA; MESOTHELIOMA; OCCUPATIONAL EXPOSURE; PLEURA EFFUSION; PLEURA PLAQUE; PLEURAL FIBROSIS; PRIORITY JOURNAL; WORKMAN COMPENSATION; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS DEVELOPMENT; EPIDEMIOLOGY; LUNG TUMOR; OCCUPATIONAL DISEASE; PERITONEUM TUMOR; PLEURA TUMOR; POLLUTANT;

ASBESTOS; ASBESTOSIS; AUSTRALIA; CAUSALITY; ENVIRONMENTAL POLLUTANTS; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; MINERAL FIBERS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PERITONEAL NEOPLASMS; PLEURAL NEOPLASMS; PULMONARY FIBROSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3943056918     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2004.10.1.40     Document Type: Conference Paper

References (36)

1. National Occupational Health and Safety Commission (NOHSC). Australian Mesothelioma Register Report 2003. Canberra, Australia: NOHSC, 2003.
2. NSWDDB. Payments according to type of dust disease (Statistics 2001, Appendix 6). Available at: 〈http://www.ddb.nsw.gov.au/parent.asp?disp= st〉.
3. Henderson DW, Rantanen J, Barnhartt S, et al. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 1997;23:311-6.
4. Aberle DR, Gamsu G, Ray CS. High resolution CT of benign asbestos related diseases: clinical and radiographic correlation. Am J Roentgenol. 1988;151:883-91.
5. Cookson W, de Klerk N, Musk A, et al. Benign and malignant pleural effusions in former Wittenoom crocidolite millers and miners. Aust NZ J Med. 1985;15:731-7.
6. Robinson B, Musk AW. Benign asbestos pleural effusion: diagnosis and course. Thorax. 1981;36:896-900.
7. Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestos associated diseases of the lungs and pleural cavity-diagnostic criteria and proposed grading system. Arch Pathol Lab Med. 1982;106:544-96.
8. Cookson WOC, Musk AW, Glancy JJ. Pleural thickening and gas transfer in asbestosis. Thorax. 1983;38:657-61.
9. Hillerdal G. Rounded atelectasis: clinical experience with 74 patients. Chest. 1989;95:836-41.
10. Gevenois PA, Maertelaer V, Madani A, et al. Astestosis, pleural plaques and diffuse pleural thickening: three distinct responses to asbestos exposure. European Respiratory J. 1998;11:1021-7.
11. Henderson DW, Shilkin KB, Whitaker D, et al. The pathology of malignant mesothelioma including immunohistology and ultrastructure. In: Henderson DW. et al. (eds). Malignant Mesothelioma. New York: Hemisphere, 1992: 69-139.
12. British Thoracic Society. Statement on malignant mesothelioma in the United Kingdom. Thorax. 2001;56:250-65.
13. Baker JE, Reutens DC, Graham DF, et al. Morphology of bronchogenic carcinoma in workers formerly exposed to crocidolite at Wittenoom Gorge in Western Australia. Int J Cancer. 1986;37:547-50.
14. Staples CA. Computed tomography in the evaluation of benign asbestos related disorders. Radiol Clin North Am. 1992;30:1191-207.
15. Murphy RL, Becklake MR, Brooks SM. The diagnosis of non malignant diseases related to asbestos. Am Rev Respir Dis. 1986;134:363-8.
16. Gaensler EA, Jederlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis. 1991;144(3Pt 1):689-96.
17. al Jarad N, Strickland B, Bothamley G, et al. Diagnosis of asbestosis by a time expanded wave form analysis, auscultation and high resolution computed tomography: a comparative study. Am J Roentgenol. 1993;48:347-53.
18. Lynch DA. CT for asbestosis: value and limitations. Am J Roentgenol. 1995;164:69-71.
19. Gamsu G, Salmon CJ, Warnock ML, et al. CT quantification of interstitial fibrosis in patients with asbestosis: a comparison of two methods. Am J Roentgenol. 1995;164:63-68.
20. Akira M, Yamamoto S, Yokoyama K, et al. Asbestosis: high resolution CT-pathologic correlation. Radiology. 1990;176:389-94.
21. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow up. J Nat Cancer Inst. 2000;92:1308-16.
22. Henschke CL. Early lung cancer action project: findings based on baseline and annual repeat screening CT. In: New Advances in Radiology and Screening of Asbestos Related Diseases. People and Work Research Reports 36. Helsinki, Finland: Finnish Institute of Occupational Health. 2000;36:31-2.
23. Summary - international expert meeting on new advances in radiology and screening of asbestos related diseases. People and Work Research Reports 36. Helsinki, Finiand: Finnish Institute of Occupational Health. 2000;36:76-84.
24. de Klerk N, Musk A, Williams V, et al. Comparison of measures of exposure to asbestos in former crocidolite workers from Wittenoom Gorge, Western Australia. Am J Ind Med. 1996;30:579-87.
25. Williams VM. Measures of Pulmonary Fibre Burden in Western Australia: Association with Exposure to Asbestos and Occurrence of Asbestos Related Diseases. PhD thesis, University of Western Australia Departments of Pathology and Public Health, 2001.
26. Williams VM. Exposure to Asbestos in Western Australia. MSc Thesis, Department of Pathology, University of Western Australia, 1996.
27. Williams V, de Klerk N, Musk A, et al. Measurement of lung tissue content of asbestos. In: Peters GA, Peters BJ (eds). Treatment and Prevention of Asbestos Diseases. Sourcebook on Asbestos Diseases. Vol. 15. Charlottesville, VA: Michie, 1997: 17-46.
28. Gylseth B, Churg A, Davis JMJ, et al. Analysis of asbestos fibers and asbestos bodies on tissue samples from human lung. An international and interlaboratory trial. Scand J Work Environ Health. 1985;11:107-10.
29. De Vuyst P, Karjalainen A, Dumortier P, et al.. Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. European Respiratory J. 1998;11:1416-26.
30. Pooley FD, Clark NJ. Quantitative assessment of inorganic fibrous particulates in dust samples with an analytical transmission electron microscope. Ann Occup Hyg. 1979;22:253-71.
31. Leigh J, Berry G, deKlerk NH, Henderson DW. Apportionment of relative contributions of asbestos and tobacco smoke for asbestos-related lung cancer. In: Peters GA, Peters BJ (eds). Sourcebook on Asbestos Diseases. Vol. 13. Charlottesville, VA: Michie, 1996: 141-66.
32. de Klerk N, Musk A, Armstrong B, et al. Smoking, exposure to crocidolite and the incidence of lung cancer and asbestosis. Br J Ind Med. 1991;48:412-7.
33. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44:565-601.
34. Green FH, Harley R, Vallyathan V, et al. . Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers. Occup Environ Med. 1997;54:549-59.
35. Multiple authors. Faserjahre BK Report 1/97 1997. Hauptverband der gewerblichen Berufsgenossenschaften, 1997.
36. Burdorf A, Swuste P. An expert system for the evaluation of historical asbestos exposure as diagnostic criterion in asbestos related diseases. Ann Occup Hyg. 1999;43:57-66.